Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹12.87Admitted-Finance CIPLA HOUSE PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL MUMBAI MAHARASHTRA 400013 | MUMBAI | MAHARASHTRA | 400013 | ₹12.87 | L1 | Admitted-Finance |
| 2 | L2₹239.51Admitted-Finance | ₹239.51 | L2 | Admitted-Finance |
| 3 | Rejected-Technical 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045 | - | - | Rejected-Technical Non Responsive |
| Sl No | Description | Qty | Unit | Cipla ltd L1 | Novartis India Limited L2 |
|---|---|---|---|---|---|
| 1.00Hemophilia Factors and Chelation Drugs | |||||
| 1.01 | Human Coagulation Factor X 250 IU | 1 | per vial | - | - |
| 1.02 | Factor VIII SHL Recombinant 250 IU | 1 | per vial | - | - |
| 1.03 | Factor VIII SHL Recombinant 500 IU | 1 | per vial | - | - |
| 1.04 | Factor VIII EHL Recombinant 250 IU | 1 | per vial | - | - |
| 1.05 | Factor 9 500 IU EHL Rifixia 500 IU | 1 | per vial | - | - |
| 1.06 | Concizumab 60 mg/1.5 ml | 1 | Per vial | - | - |
| 1.07 | Concizumab 150 mg/1.5 ml | 1 | Per vial | - | - |
| 1.08 | Cap Deferiprone 250 mg | 1 | Per Capsule | 4 ₹4 | - |
| 1.09 | Cap Deferiprone 500 mg | 1 | Per Capsule | 8.87 ₹8.87 | - |
Updated dates
Tender Value
Refer Docs
Closing Date
18 May 2026, 11:30 amClosed
Managing Director PHSC
Managing Director, Punjab Health Systems Corporation, Second Floor, E-Block, Punjab School Education Board Complex, Opposite Fortis Hospital, Phase 8 SAS Nagar Mohali
Hemophilia Factors and Chelation Drugs
2026_DHFW_167728_1
PHSC/Proc/2026/15
Open Tender
Medical Equipments/Waste
180 days
SAS Nagar Mohali
As per DNIt
3 documents required · 3 mandatory
₹2,000
Exempted
24 Jun 2026
6 May 2026
19 May 2026
6 May 2026
18 May 2026
6 May 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount | Item Code |
|---|---|---|---|---|---|---|
| 1Hemophilia Factors and Chelation Drugs | ||||||
| 1.01 | Human Coagulation Factor X 250 IU | 1 | per vial | - | - | C1 |
| 1.02 | Factor VIII SHL Recombinant 250 IU | 1 | per vial | - | - | C2 |
| 1.03 | Factor VIII SHL Recombinant 500 IU | 1 | per vial | - | - | C3 |
| 1.04 | Factor VIII EHL Recombinant 250 IU | 1 | per vial | - | - | C4 |
| 1.05 | Factor 9 500 IU EHL Rifixia 500 IU | 1 | per vial | - | - | C8 |
| 1.06 | Concizumab 60 mg/1.5 ml | 1 | Per vial | - | - | C11 |
| 1.07 | Concizumab 150 mg/1.5 ml | 1 | Per vial | - | - | C12 |
| 1.08 | Cap Deferiprone 250 mg | 1 | Per Capsule | - | - | C13 |
| 1.09 | Cap Deferiprone 500 mg | 1 | Per Capsule | - | - | C14 |
stage.html
html • 0.03 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.49 MB
Tendernotice_2.pdf
PDF • 1.09 MB
BOQ_340963.xls
BOQ • 0.34 MB
Download all tender documents and submit your bid